However, due to the pleiotropic nature of NGF action, the effect of inhibiting NGF-TrkA signalling in arthritis treatment remains controversial, and it is not clear whether there are significant negative effects (Walsh and Neogi, 2019). The gene discussed is NTRK1; the disease is Arthritis.